Automated Endoscope Reprocessors Market

By Product;

Single Basin AER and Dual Basin AER

By Modality;

Standalone AER and Bench Top AER

By End User;

Hospitals, Ambulatory Surgical Centers and Clinics

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn154242486 Published Date: August, 2025

Automated Endoscope Reprocessors Market Overview

Automated Endoscope Reprocessors Market (USD Million)

Automated Endoscope Reprocessors Market was valued at USD 3,568.61 million in the year 2024. The size of this market is expected to increase to USD 5,004.67 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.0%.


Automated Endoscope Reprocessors Market

*Market size in USD million

CAGR 5.0 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.0 %
Market Size (2024)USD 3,568.61 Million
Market Size (2031)USD 5,004.67 Million
Market ConcentrationMedium
Report Pages305
3,568.61
2024
5,004.67
2031

Major Players

  • Custom Ultrasonics Inc
  • STERIS Plc
  • Hoya Corporation
  • Olympus Corporation
  • Advanced Sterilization Products Services Inc
  • Laboratory Anios
  • Getinge AB
  • Metull Zug AG
  • Steelco S.p.A.
  • Cantel Medical Corp
  • Johnson & Johnson

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Automated Endoscope Reprocessors Market

Fragmented - Highly competitive market without dominant players


The Automated Endoscope Reprocessors (AERs) Market is expanding rapidly as healthcare institutions intensify efforts to maintain sterilization standards. More than 72% of hospitals have adopted automated cleaning systems to ensure disinfection consistency and patient safety. These devices significantly reduce manual intervention, thereby lowering the risk of contamination.

Shift Toward Automation
A growing number of endoscopy units—over 65%—are now relying on automated reprocessing solutions over traditional manual methods. The increasing focus on compliance, efficiency, and process reliability is driving this trend, enabling faster turnaround times and consistent sterilization outcomes.

Growth in Procedure Volumes
The rising number of diagnostic and therapeutic endoscopic procedures, which has gone up by 48%, is accelerating demand for efficient reprocessing units. AERs help facilities handle higher procedural volumes by offering speed and performance, making them essential in modern clinical workflows.

Smart Features Driving Adoption
Advanced AER models now feature smart tracking systems and digital documentation tools, with nearly 53% of installations including these upgrades. These features not only enhance operational transparency but also improve equipment maintenance and regulatory compliance across healthcare environments.

This report provides an in depth analysis of various factors that impact the dynamics of Global Automated Endoscope Reprocessors Market. These factors include; Market Drivers, Restraints, and Opportunities.

Drivers, Restraints and Opportunity Analysis

Drivers

  • Increasing demand for minimally invasive procedures
  • Growing awareness about infection control
  • Expansion of healthcare infrastructure
  • Rising demand for endoscopic procedures
  • Focus on preventive healthcare measures - Preventive healthcare measures serve as a significant driver in the global automated endoscope reprocessors market. Healthcare facilities and regulatory bodies worldwide increasingly prioritize infection prevention and control as a fundamental aspect of patient care. Automated endoscope reprocessors (AERs) play a pivotal role in this regard by ensuring the effective sterilization and disinfection of endoscopes, thereby mitigating the risk of healthcare-associated infections (HAIs).

    The emphasis on preventive healthcare measures stems from the recognition of HAIs as a major public health concern. HAIs can lead to significant morbidity, mortality, and healthcare costs, making their prevention a top priority for healthcare providers and policymakers. By implementing stringent infection control protocols, including the use of automated reprocessing systems, healthcare facilities can reduce the transmission of pathogens and safeguard patient safety.

    The growing awareness about infection control among healthcare professionals, patients, and the general public also contributes to the demand for automated endoscope reprocessors. Healthcare providers are increasingly cognizant of the importance of implementing comprehensive infection prevention strategies to protect patient safety and improve healthcare outcomes. Patients, too, are becoming more proactive in seeking care from facilities that prioritize infection control measures.

Restraints

  • Concerns about system efficacy
  • Limited skilled personnel availability
  • Regulatory complexities
  • Equipment reliability concerns
  • Liability issues - Liability issues pose a significant restraint in the global automated endoscope reprocessors market. Healthcare facilities and manufacturers face potential legal and financial consequences if endoscope reprocessing protocols are not effectively implemented or if reprocessed endoscopes lead to patient harm. Inadequate reprocessing practices can result in the transmission of pathogens, leading to healthcare-associated infections (HAIs) and patient morbidity.

    Healthcare providers may be held liable for negligence or malpractice if they fail to adhere to regulatory standards or industry best practices in endoscope reprocessing. Legal claims related to HAIs caused by contaminated endoscopes can result in costly litigation, damage to reputation, and financial penalties for healthcare facilities. Manufacturers of automated endoscope reprocessors may also face liability claims if their devices are found to be defective or if they fail to meet regulatory requirements.

    The complexity of liability issues in the context of endoscope reprocessing arises from multiple factors, including the variability of reprocessing protocols, the potential for human error, and the evolving nature of regulatory standards. Healthcare facilities must navigate a complex legal landscape to ensure compliance with regulatory requirements and mitigate the risk of liability. This may involve investing in comprehensive staff training programs, implementing robust quality assurance measures, and maintaining detailed documentation of reprocessing procedures.

Opportunities

  • Portfolio expansion
  • Strategic partnerships
  • Cloud-based solutions adoption
  • AI and machine learning integration
  • User-friendly design enhancements - User-friendly design enhancements present a compelling opportunity in the global automated endoscope reprocessors market. As healthcare facilities strive to optimize workflow efficiency and streamline endoscope reprocessing procedures, there is a growing demand for automated reprocessing systems that are intuitive, easy to use, and require minimal training.

    By focusing on user-friendly design enhancements, manufacturers can improve the usability and accessibility of automated endoscope reprocessors, making them more appealing to healthcare professionals across different skill levels. Intuitive interfaces, simplified control panels, and guided workflows can help reduce the likelihood of errors and streamline the reprocessing process, ultimately enhancing efficiency and productivity in healthcare settings.

    User-friendly design enhancements can contribute to staff satisfaction and morale by reducing the burden of manual tasks and repetitive processes associated with endoscope reprocessing. Healthcare providers may be more inclined to adopt automated reprocessing technology if it offers a seamless and user-friendly experience, leading to increased utilization and improved compliance with reprocessing protocols.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Modality
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Automated Endoscope Reprocessors Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing demand for minimally invasive procedures
        2. Growing awareness about infection control
        3. Expansion of healthcare infrastructure
        4. Rising demand for endoscopic procedures
        5. Focus on preventive healthcare measures
      2. Restraints
        1. Concerns about system efficacy
        2. Limited skilled personnel availability
        3. Regulatory complexities
        4. Equipment reliability concerns
        5. Liability issues
      3. Opportunities
        1. Portfolio expansion
        2. Strategic partnerships
        3. Cloud-based solutions adoption
        4. AI and machine learning integration
        5. User-friendly design enhancements
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Automated Endoscope Reprocessors Market, By Product, 2021-2031 (USD Million)
      1. Single Basin AER
      2. Dual Basin AER
    2. Automated Endoscope Reprocessors Market, By Modality, 2021-2031 (USD Million)
      1. Standalone AER
      2. Bench top AER
    3. Automated Endoscope Reprocessors Market, By End User, 2021-2031 (USD Million)
      1. Hospitals
      2. Ambulatory Surgical Centers
      3. Clinics
    4. Automated Endoscope Reprocessors Market, By Geography, 2021-2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Custom Ultrasonics Inc
      2. STERIS Plc
      3. Hoya Corporation
      4. Olympus Corporation
      5. Advanced Sterilization Products Services Inc
      6. Laboratory Anios
      7. Getinge AB
      8. Metull Zug AG
      9. Steelco S.p.A.
      10. Cantel Medical Corp
      11. Johnson & Johnson
  7. Analyst Views
  8. Future Outlook of the Market